US Stock MarketDetailed Quotes

CRBU Caribou Biosciences

Watchlist
  • 3.760
  • -0.090-2.34%
Close Apr 25 16:00 ET
339.58MMarket Cap-2724P/E (TTM)

Caribou Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
148.91%34.48M
-3.63%3.56M
616.38%23.66M
-10.42%3.76M
31.46%3.5M
44.31%13.85M
44.28%3.69M
-16.95%3.3M
184.01%4.19M
67.97%2.66M
Operating revenue
148.91%34.48M
-3.63%3.56M
616.38%23.66M
-10.42%3.76M
31.46%3.5M
44.31%13.85M
44.28%3.69M
-16.95%3.3M
184.01%4.19M
67.97%2.66M
Cost of revenue
Gross profit
Operating expense
25.19%150.54M
19.64%41M
28.33%38.3M
12.26%36.62M
47.20%34.62M
57.03%120.25M
49.23%34.27M
32.08%29.84M
87.06%32.62M
59.32%23.52M
Selling and administrative expenses
1.16%38.46M
13.91%9.72M
-1.40%9.71M
0.76%10.12M
-7.13%8.91M
56.32%38.02M
8.67%8.53M
45.70%9.85M
96.44%10.04M
108.72%9.59M
-General and administrative expense
1.16%38.46M
13.91%9.72M
-1.40%9.71M
0.76%10.12M
-7.13%8.91M
56.32%38.02M
8.67%8.53M
45.70%9.85M
96.44%10.04M
108.72%9.59M
Research and development costs
36.29%112.08M
21.54%31.28M
42.98%28.58M
17.38%26.5M
84.64%25.71M
57.36%82.23M
70.31%25.74M
26.26%19.99M
83.17%22.58M
36.98%13.92M
Operating profit
-9.08%-116.06M
-22.45%-37.44M
44.86%-14.63M
-15.61%-32.87M
-49.22%-31.12M
-58.85%-106.4M
-49.86%-30.58M
-42.55%-26.54M
-78.09%-28.43M
-58.28%-20.85M
Net non-operating interest income expense
Other net income (expense)
101.22%14.18M
-14.46%3.13M
4,310.00%4.63M
93.14%3.35M
74.05%3.07M
1,769.50%7.05M
62.84%3.66M
95.34%-110K
4.90%1.73M
10,931.25%1.77M
Gain on sale of security
95.49%-6K
85.00%-9K
-112.90%-4K
237.50%22K
82.95%-15K
---133K
---60K
--31K
---16K
---88K
Other non- operating income (expenses)
97.58%14.19M
-15.60%3.14M
3,387.23%4.64M
90.11%3.33M
66.59%3.09M
694.95%7.18M
65.51%3.72M
94.02%-141K
2,436.23%1.75M
11,481.25%1.85M
Income before tax
-2.54%-101.88M
-27.46%-34.31M
62.46%-10M
-10.57%-29.52M
-46.92%-28.04M
-49.17%-99.35M
-48.25%-26.92M
-27.05%-26.65M
-86.55%-26.7M
-45.06%-19.09M
Income tax
175.71%193K
-78.19%70K
Net income
-2.66%-102.07M
-27.85%-34.51M
62.46%-10M
-10.57%-29.52M
-46.92%-28.04M
-48.56%-99.42M
-46.05%-26.99M
-27.05%-26.65M
-86.55%-26.7M
-45.06%-19.09M
Net income continuous Operations
-2.66%-102.07M
-27.85%-34.51M
62.46%-10M
-10.57%-29.52M
-46.92%-28.04M
-48.56%-99.42M
-46.05%-26.99M
-27.05%-26.65M
-86.55%-26.7M
-45.06%-19.09M
Minority interest income
Net income attributable to the parent company
-2.66%-102.07M
-27.85%-34.51M
62.46%-10M
-10.57%-29.52M
-46.92%-28.04M
-48.56%-99.42M
-46.05%-26.99M
-27.05%-26.65M
-86.55%-26.7M
-45.06%-19.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-2.66%-102.07M
-27.85%-34.51M
62.46%-10M
-10.57%-29.52M
-46.92%-28.04M
-48.56%-99.42M
-46.05%-26.99M
-27.05%-26.65M
-86.55%-26.7M
-45.06%-19.09M
Basic earnings per share
15.85%-1.38
9.09%-0.4
72.73%-0.12
-9.09%-0.48
-43.75%-0.46
22.27%-1.64
-41.94%-0.44
4.35%-0.44
-68.21%-0.44
32.74%-0.32
Diluted earnings per share
15.85%-1.38
9.09%-0.4
72.73%-0.12
-9.09%-0.48
-43.75%-0.46
22.27%-1.64
-41.94%-0.44
4.35%-0.44
-68.21%-0.44
32.74%-0.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 148.91%34.48M-3.63%3.56M616.38%23.66M-10.42%3.76M31.46%3.5M44.31%13.85M44.28%3.69M-16.95%3.3M184.01%4.19M67.97%2.66M
Operating revenue 148.91%34.48M-3.63%3.56M616.38%23.66M-10.42%3.76M31.46%3.5M44.31%13.85M44.28%3.69M-16.95%3.3M184.01%4.19M67.97%2.66M
Cost of revenue
Gross profit
Operating expense 25.19%150.54M19.64%41M28.33%38.3M12.26%36.62M47.20%34.62M57.03%120.25M49.23%34.27M32.08%29.84M87.06%32.62M59.32%23.52M
Selling and administrative expenses 1.16%38.46M13.91%9.72M-1.40%9.71M0.76%10.12M-7.13%8.91M56.32%38.02M8.67%8.53M45.70%9.85M96.44%10.04M108.72%9.59M
-General and administrative expense 1.16%38.46M13.91%9.72M-1.40%9.71M0.76%10.12M-7.13%8.91M56.32%38.02M8.67%8.53M45.70%9.85M96.44%10.04M108.72%9.59M
Research and development costs 36.29%112.08M21.54%31.28M42.98%28.58M17.38%26.5M84.64%25.71M57.36%82.23M70.31%25.74M26.26%19.99M83.17%22.58M36.98%13.92M
Operating profit -9.08%-116.06M-22.45%-37.44M44.86%-14.63M-15.61%-32.87M-49.22%-31.12M-58.85%-106.4M-49.86%-30.58M-42.55%-26.54M-78.09%-28.43M-58.28%-20.85M
Net non-operating interest income expense
Other net income (expense) 101.22%14.18M-14.46%3.13M4,310.00%4.63M93.14%3.35M74.05%3.07M1,769.50%7.05M62.84%3.66M95.34%-110K4.90%1.73M10,931.25%1.77M
Gain on sale of security 95.49%-6K85.00%-9K-112.90%-4K237.50%22K82.95%-15K---133K---60K--31K---16K---88K
Other non- operating income (expenses) 97.58%14.19M-15.60%3.14M3,387.23%4.64M90.11%3.33M66.59%3.09M694.95%7.18M65.51%3.72M94.02%-141K2,436.23%1.75M11,481.25%1.85M
Income before tax -2.54%-101.88M-27.46%-34.31M62.46%-10M-10.57%-29.52M-46.92%-28.04M-49.17%-99.35M-48.25%-26.92M-27.05%-26.65M-86.55%-26.7M-45.06%-19.09M
Income tax 175.71%193K-78.19%70K
Net income -2.66%-102.07M-27.85%-34.51M62.46%-10M-10.57%-29.52M-46.92%-28.04M-48.56%-99.42M-46.05%-26.99M-27.05%-26.65M-86.55%-26.7M-45.06%-19.09M
Net income continuous Operations -2.66%-102.07M-27.85%-34.51M62.46%-10M-10.57%-29.52M-46.92%-28.04M-48.56%-99.42M-46.05%-26.99M-27.05%-26.65M-86.55%-26.7M-45.06%-19.09M
Minority interest income
Net income attributable to the parent company -2.66%-102.07M-27.85%-34.51M62.46%-10M-10.57%-29.52M-46.92%-28.04M-48.56%-99.42M-46.05%-26.99M-27.05%-26.65M-86.55%-26.7M-45.06%-19.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -2.66%-102.07M-27.85%-34.51M62.46%-10M-10.57%-29.52M-46.92%-28.04M-48.56%-99.42M-46.05%-26.99M-27.05%-26.65M-86.55%-26.7M-45.06%-19.09M
Basic earnings per share 15.85%-1.389.09%-0.472.73%-0.12-9.09%-0.48-43.75%-0.4622.27%-1.64-41.94%-0.444.35%-0.44-68.21%-0.4432.74%-0.32
Diluted earnings per share 15.85%-1.389.09%-0.472.73%-0.12-9.09%-0.48-43.75%-0.4622.27%-1.64-41.94%-0.444.35%-0.44-68.21%-0.4432.74%-0.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Gene Editing
Gene Editing
Intraday-1.09%